Replies to post #403826 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

I have given an answer to this question at least twice and you seem to ignore it.

How earth can the company make a claim to have met all endpoints, while at same time confessing they did not have the data until a day before CTAD and the P2b/3 readout PR.

You will have the answer to this innuendo when the company publishes more data as it says it will. If the company does have ground breaking results we will see them when the company wants us to.

Meeting endpoints will be determined by the FDA and other agencies. What we determine on a message board has no impact on that. The company has repeatedly said it met the endpoints. Because of the consequences of that not being true, I will accept what the company says until shown otherwise.

[Joseph_K]

As for the "lack of primary endpoint time/response charts," why do you feel Anavex's claims stated in this earlier post of mine fail to fill that void?